Guillain-Barré Syndrome after COVID-19 accompanied byDysautonomia

The COVID-19 pandemic that emerged in Wuhan, Hubei Province, China in December 2019 is ongoing. COVID-19 may also cause neurological symptoms with central or peripheral nervous system or skeletal muscle involvement. Guillain–Barré syndrome (GBS) is an autoimmune disorder of the peripheral nervous system that is usually triggered by bacterial or viral infections. Autonomic nerve involvement can be seen in GBS. Case reports suggest that GBS is linked to COVID-19 infection. Here, we present a case of GBS occurring after COVID-19, accompanied by dysautonomia.

PDF

___

1. Sedaghat Z , Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. Case Reports / J Clin Neurosci 2020;76 :233-5.
2. Rahimi K. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports. Neurological Sciences 2020.
3. Zhao Y, Zhao Z, Wang Y, et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv 2020, published online 26 January.
4. Chen N, Zhou M, Dong X, , et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13.
5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
6. Mao L, Wang M, Chen Sh, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study. JAMA Neurol 2020.
7. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of GuillainBarré syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011;36:123-33.
8. Chakraborty T, Kramer CL , Wijdicks EFM, Rabinstein AA. Dysautonomia in Guillain–Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes. Neurocrit Care 2020;32:113-20.
9. Guillain G, Barré JA, Strohl A. Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes. 1916.Ann Med Interne 1999;150:24-32.
10. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012;366:2294-304.
11. Sahin AR, Erdogan A, Mutlu Agaoglu P, et al. 2019 Novel Coronavirus (COVID-Outbreak: A Review of the Current Literature. EJMO 2020;4:1-7.14.
12. Kim JE, Heo JH, Ho Kim, et al. Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol 2017;13:227-33.
13. Montalvan V, Lee J, Bueso T, et al.Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg 2020;194:105921.
14. Zhao H, Shen D, Zhou H, et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? The Lancet Neurology 2020;19:383-84.
15. Su XW, Palka SV, Rao RR, et al. SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia. Muscle & Nerve. 2020;1-2.
16. Sharma K, Tengsupakul S, Sanchez O, et al. GuillainBarré syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report. SAGE Open Med Case Rep 2019;7:2050313X19838750-2050313X.
17. Chan JL, Ebadi H, Sarna JR. Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection. Can J Neurol Sci 2020;47:852-4.
18. Su XW, Palka SV, Rao RR, et al. SARS-CoV-2 associated Guillain-Barre syndrome with dysautonomia. Muscle & Nerve.n/a(n/a).
19. Zaeem Z, Siddiqi ZZ , Zochodne DW. Autonomic involvement in Guillain–Barré syndrome: an update. Clin Auton Res 2019;29:289-99.
20. Ropper AH, Wijdicks EFM, Truax BT. Guillain–Barré syndrome. Contemporary neurology series. FA Davis, Philadelphia 1991.